PATENT CLAIM ANALYSIS

Application Number: 16215296
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["546", "276400"]

Abstract:
The invention provides chiral haptens (−)-3′-AmNic and (−)-N4N for use in generating antibodies in a patient specific for (−)-nicotine. The haptens can be conjugated to suitable carrier proteins and administered as an antigenic mixture, optionally comprising adjuvant(s), to a patient suffering from nicotine or tobacco addiction or habituation.

Claim (Index 6):
The process according to any one of  claims 1 - 5 , wherein step (D) occurs in toluene.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.42222
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12836165', '11780742', '10909841', '13151590', '15306466']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7937688533436745
- 35 USC 102 Novelty (BERT): 0.5229773094491242
- Combined Prediction Score: 0.7666896989542195
- Mean Citation Score: 246.70369800000003
- Max Citation Score: 258.7228
- Similarity Product: 126.0039377551794

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test